Well Done LLC’s AngioDynamics ANGO Stock Holding History

Well Done LLC’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-281	Closed	-$6K	–	173
2018 Q4	$6K	Buy	+281	New	+$5.82K	﹤0.01%	546

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Well Done LLC's ANGO Position: Q1 2019 in Review

Well Done LLC sold out of AngioDynamics (ANGO) in Q1 2019, closing a stake of 281 shares — an estimated $6K sold.

Well Done LLC first reported a position in ANGO in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 179 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

Well Done LLC reported no remaining AngioDynamics position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 281 AngioDynamics shares in Q1 2019, an estimated $6K.
Well Done LLC first reported a position in AngioDynamics in Q4 2018 and held it in 1 quarter.
Well Done LLC's AngioDynamics position peaked at $6K in Q4 2018.
179 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.